Comparison of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization

被引：0
|
作者：
Brueck, M. [1 ]
Cengiz, H. [1 ]
Boening, A. [2 ]
机构：
[1] Clin Wetzlar, Dept Cardiol, Wetzlar, Germany
[2] Univ Giessen, Dept Cardiovasc Surg, D-35390 Giessen, Germany
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：261 / 262
页数：2
相关论文
共 50 条
  • [21] Preventive effect of coenzyme Q10 combined with trimetazidine on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization
    Chen, Fei
    Yang, Xiuchun
    Zhang, Jie
    Liu, Fan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C132 - C132
  • [22] Role of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy: A Meta-analysis
    Loomba, Rohit S.
    Shah, Parinda H.
    Aggarwal, Saurabh
    Arora, Rohit R.
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (01) : E172 - E183
  • [23] Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN)
    Ng, Tien M. H.
    Shurmur, Scott W.
    Silver, Mary
    Nissen, Lindsay R.
    O'Leary, Edward L.
    Rigmaiden, Richard S.
    Cieciorka, Mike
    Porter, Laura L.
    Ineck, Beata A.
    Kline, Mary E.
    Puumala, Susan E.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 109 (03) : 322 - 328
  • [24] Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
    Arabmomeni, Morteza
    Najafian, Jamshid
    Esfahani, Morteza Abdar
    Samadi, Mohsen
    Mirbagher, Leila
    ARYA ATHEROSCLEROSIS, 2015, 11 (01) : 43 - 49
  • [25] N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial
    Amini, Manouchehr
    Salarifar, Mojtaba
    Amirbaigloo, Alireza
    Masoudkabir, Farzad
    Esfahani, Fatemeh
    TRIALS, 2009, 10
  • [26] N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial
    Manouchehr Amini
    Mojtaba Salarifar
    Alireza Amirbaigloo
    Farzad Masoudkabir
    Fatemeh Esfahani
    Trials, 10
  • [27] Impact of Contrast-Induced Nephropathy and Cardiovascular Events by Serum Cystatin C in Renal Insufficiency Patients Undergoing Cardiac Catheterization
    Ishibashi, Yuki
    Yamauchi, Masahiro
    Musha, Haruki
    Mikami, Taishi
    Kawasaki, Kensuke
    Miyake, Fumihiko
    ANGIOLOGY, 2010, 61 (08) : 724 - 730
  • [28] Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin c in patients with renal insufficiency undergoing cardiac catheterization
    Ishibashi, Y.
    Yamauchi, M.
    Akashi, Y.
    Musha, H.
    Miyake, F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 380 - 380
  • [29] Preventive Effect of N-Acetylcysteine in Contrast-Induced Nephropathy during Elective Coronary Intervention
    Sagara, Shuichiro
    Sadamatsu, Kenji
    Isa, Yasuki
    Nagaoka, Kazuhiro
    Shikada, Tomoki
    Ooe, Kensuke
    Morishige, Kunio
    Tanaka, Eriko
    Yamawaki, Tohru
    Ishibashi, Yuji
    Tashiro, Hideki
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (9A): : 108B - 108B
  • [30] Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiac procedures
    Gowda, RM
    Shapiro, M
    Khan, IA
    Leibowitz, K
    Misra, D
    CHEST, 2004, 126 (04) : 710S - 710S
12345